Sibling Watch: Kinship-Based ADHD Monitoring After a Child's Diagnosis
A system that monitors the siblings of a child with ADHD to catch symptoms in them as early as possible.
When a child is diagnosed with ADHD, this tool maps the family and automatically puts brothers and sisters — who face roughly eight times the average risk — on a light schedule of periodic parent and teacher checklists, so a second affected child is spotted years earlier.
Concept
Sibling Watch is a kinship-stratified monitoring service triggered the day a child receives an ADHD diagnosis. At the diagnostic visit, the clinician completes a two-minute structured family-history form (twins, siblings, half-siblings, cousins, affected parents). The tool then:
- Scores each relative's recurrence risk from documented kinship — the population-scale figures in the source review imply roughly 70x baseline risk for a monozygotic co-twin, ~8x for a full sibling or dizygotic twin, and ~1.5x even for a half-cousin.
- Enrolls full siblings and any twin in lightweight 'watchful waiting' — brief parent and teacher rating scales repeated every 6–12 months, with automatic prompts to refer for assessment if scores cross a threshold.
- Gives parents a plain-language psychoeducation pack on what early signs look like in a sibling, so monitoring continues at home between visits.
Delivered as a module inside pediatric EHRs or CAMHS workflows, it turns the strongest and cheapest risk predictor available at the moment of diagnosis — the family itself — into an operational early-identification pathway. It is monitoring, not diagnosis: the output is a prioritized watchlist, not a label.
Why now
Paper [0] consolidates the quantitative genetics that make this actionable: total ADHD heritability of 70–80% (stable across childhood and adolescence), kinship hazard ratios of ~70 for monozygotic twins, ~8 for dizygotic twins/full siblings, and ~1.5 for half-cousins from a large population sample — and, critically, common-variant (SNP) heritability of only 14–22%, meaning polygenic scores are not yet clinically useful while documented family history already is. Older corpus papers [4] and [5] confirm the high-heritability, multifactorial etiology and the guideline priority on timely identification and intervention. Existing case-finding approaches audit general practice records for missed cases; none act prospectively on the relatives of the newly diagnosed, where risk is most concentrated and the intervention (a few rating scales) is cheapest.
Written by GLM · 11 Oct 2026
AI assessment
A high-utility, low-friction clinical wedge that leverages strong genetic heritability data to move ADHD identification from reactive to proactive within families.
- Evidence strength 5/5
- The idea is directly grounded in the specific hazard ratios (70x for MZ twins, 8x for siblings) and heritability percentages (70-80%) provided in the full-text digest of Paper [3].
- Market pull 4/5
- Pediatric clinics and NHS trusts have a strong mandate for early intervention, and the 'watchful waiting' approach reduces the burden on diagnostic pipelines while increasing capture rates.
- Novelty & moat 4/5
- While other catalog ideas focus on comorbidities or medication monitoring for the diagnosed child, this is the first to operationalize kinship-based prospective screening for unaffected relatives.
- Feasibility 5/5
- The MVP requires only a simple kinship form and the automation of existing validated rating scales (like Vanderbilt or Conners), making it highly buildable.
- Wedge clarity 5/5
- The wedge is extremely sharp: a trigger event (diagnosis of child A) leads to a specific action (monitoring of sibling B).
- Simplicity / focus 5/5
- It avoids 'platform' creep by focusing on a single, clear workflow: kinship mapping followed by periodic checklist prompts.
Scored by Gemma 4 · 11 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- South London and Maudsley NHS Foundation Trustorganization
As one of the UK's largest CAMHS providers, SLaM could convert every new pediatric ADHD diagnosis into earlier identification of the ~8x-risk siblings, improving outcomes while managing referral demand with cheap periodic checklists rather than crisis presentations.
- Qbtechcompany
Qbtech sells the QbTest objective ADHD assessment into NHS services; a family-history triage layer identifying which siblings to test would feed higher-yield referrals directly into its existing diagnostic workflow.
- ADHD Foundationorganization
The ADHD Foundation runs family support and neurodiversity education programs; an evidence-based sibling-recurrence psychoeducation pack gives the families it serves a concrete next step after a diagnosis.
- Pearson Clinical Assessmentcompany
Pearson publishes pediatric attention and executive-function assessments; embedding kinship-risk stratification and sibling monitoring schedules would extend its portfolio from one-off testing into longitudinal family pathways.
Research it builds on
- Evidence-based pharmacological treatment options for ADHD in children and adolescentsKonstantin Mechler, Tobias Banaschewski, Sarah Hohmann et al. · 2021 · 296 citationsAll ideas from this paper →
- The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)David Coghill, Tobias Banaschewski, Samuele Cortese et al. · 2021 · 178 citationsAll ideas from this paper →
- An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorderBruna Santos da Silva, Eugenio Horácio Grevet, Luíza Carolina Fagundes Silva et al. · 2023 · 117 citationsAll ideas from this paper →